Molecular Pathology Preauthorization:  BCBSTX/eviCore's Process Reviewed  

Effective Feburary 1, 2018 Blue Cross Blue Shield of Texas (BCBSTX) and eviCore changed their molecular pathology preauthorization requirements. To help you and your office staff understand BCBSTX/eviCore's process, the Texas Society of Pathologists is pleased to offer a webinar. Representatives of BCBSTX and eviCore will review their preauthorization processes and you will have an opportunity to get all of your questions answered. 

Join us this Thursday, April 26 from 3 - 4 p.m.


© Texas Society of Pathologists